Deep-learning technology reveals anti-aging plant extracts

Life Extension, in collaboration with Insilico Medicine, have employed artificial intelligence to develop a novel dietary supplement of plant extracts that can activate the body's own anti-aging path ways.

Insilico, a next-generation artificial intelligence company specializing in the application of deep learning proprietary technology for biomarker development and aging research, used pioneering high-performance computer simulations to probe of the effect of extracts on anti-aging pathways. The resulting formulation, called Longevity A.I, is an innovative combination of three natural nutrients that mimic known metabolic regulators of the same anti-aging pathways targeted by calorie restriction mimetics, which have long been associated with increased life expectancy.

The active ingredients, Withaferin A, Ginsenoside Rg3 and Gamma linolenic acid, shown by recent scientific studies to increase longevity, were identified from combinations of thousands of other candidates using deep-learning technology which calculated the precise formula for maximum activation of the anti-aging pathways.

"GEROPROTECTTM Longevity A.I. is the only formation to combine these three potential life-prolonging ingredients into a single supplement," says Andrew G. Swick, Ph.D., senior vice president, product development and scientific affairs at Fort Lauderdale, Fla.-based Life Extension. "This unique formulation based on proprietary artificial intelligence technology contains these geroprotector ingredients in concentrations several magnitudes higher than conventional dietary supplements. We suggest that this novel formulation should be a keystone product all life extensionists' supplement regimens." Suggested retail price for 30 softgels of GEROPROTECTTM Longevity A.I is $56.

Advertisement

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Traumatic brain injury biomarker could help predict patient prognosis